Carson Wealth (CWM LLC)
RCKT icon

Carson Wealth (CWM LLC)’s Rocket Pharmaceuticals RCKT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$624K Buy
174,263
+141,783
+437% +$564K ﹤0.01% 1851
2025
Q4 		$114K Buy
32,480
+665
+2% +$2.28K ﹤0.01% 2972
2025
Q3 		$104K Buy
31,815
+16,005
+101% +$50.4K ﹤0.01% 2962
2025
Q2 		$39K Buy
15,810
+2,587
+20% +$13.1K ﹤0.01% 3470
2025
Q1 		$88K Buy
13,223
+9,498
+255% +$93.8K ﹤0.01% 2529
2024
Q4 		$47K Buy
3,725
+2,463
+195% +$37.1K ﹤0.01% 2851
2024
Q3 		$23K Buy
1,262
+30
+2% +$614 ﹤0.01% 3276
2024
Q2 		$27K Buy
1,232
+14
+1% +$322 ﹤0.01% 2924
2024
Q1 		$33K Hold
1,218
– – ﹤0.01% 2582
2023
Q4 		$37K Sell
1,218
-35
-3% -$772 ﹤0.01% 2364
2023
Q3 		$26K Buy
1,253
+35
+3% +$636 ﹤0.01% 2508
2023
Q2 		$24K Hold
1,218
– – ﹤0.01% 2519
2023
Q1 		$21K Hold
1,218
– – ﹤0.01% 2480
2022
Q4 		$24K Hold
1,218
– – ﹤0.01% 2247
2022
Q3 		$19K Hold
1,218
– – ﹤0.01% 2262
2022
Q2 		$17K Buy
1,218
+1,197
+5,700% +$14.3K ﹤0.01% 2229
2022
Q1 		$0 Sell
21
-15
-42% -$259 ﹤0.01% 3812
2021
Q4 		$1K Buy
+36
New +$982 ﹤0.01% 3363

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RCKT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Rocket Pharmaceuticals (RCKT) stake by 437% in Q1 2026, buying an estimated $564K and bringing the position to 174,263 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Carson Wealth (CWM LLC) first reported a position in RCKT in Q4 2021 and has held it in 18 quarters since. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 174,263 shares of Rocket Pharmaceuticals worth $624K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 141,783 Rocket Pharmaceuticals shares in Q1 2026, an estimated $564K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1851 holding.
  • Carson Wealth (CWM LLC) first reported a position in Rocket Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.